Showing results (261-270 of 1,607) with videos related to
Sort By:
Pageof 161
JAMA Oncology|July 28, 2017
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A ReviewMeghan Thompson, Danielle Brander, Chadi Nabhan, et al.JAMA Oncology|July 18, 2017
Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk GroupHiten D Patel, Jeffrey J Tosoian, H Ballentine Carter, et al.JAMA Oncology|August 25, 2017
Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral TherapyFahad Mukhtar, Mmadili Ilozumba, Ovie Utuama, et al.JAMA Oncology|August 25, 2017
Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant ChemotherapyThomas Seisen, Asha Jamzadeh, Jeffrey J Leow, et al.JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.JAMA Oncology|November 20, 2015
Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood OsteosarcomaMichelle N Edelmann, Vinay M Daryani, Michael W Bishop, et al.JAMA Oncology|December 4, 2015
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer SurvivorsShelli R Kesler, Douglas W BlayneyJAMA Oncology|December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer RecurrenceMichail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.JAMA Oncology|December 4, 2015
Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical DevelopmentAmy S Clark, Thomas B Karasic, Angela DeMichele, et al.JAMA Oncology|November 26, 2015
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical TrialBenjamin Movsas, Chen Hu, Jeffrey Sloan, et al.Pageof 161